XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Redeemable Noncontrolling Interest
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance, beginning of period at Dec. 25, 2022   $ 11.2        
Redeemable Noncontrolling Interest            
Net income (loss)   1.2        
Balance, end of period at Mar. 26, 2023   12.4        
Balance, beginning of period (in shares) at Dec. 25, 2022     126,000,000.0      
Balance, beginning of period at Dec. 25, 2022 $ 936.3   $ 0.0 $ 1,608.4 $ (0.8) $ (671.3)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 6.6     6.6    
Issuance of common stock for employee stock purchase plan and stock options (in shares)     300,000      
Issuance of common stock for employee stock purchase plan and stock options 2.9     2.9    
Restricted stock issued and related taxes (in shares)     400,000      
Restricted stock issued and related taxes (2.6)     (2.6)    
Gain on interest rate swap contract 0.0          
Net income (loss) (7.0)         (7.0)
Other comprehensive income (loss), net of tax 0.3       0.3  
Changes in noncontrolling interest (5.3)     (5.3)    
Balance, end of period (in shares) at Mar. 26, 2023     126,700,000      
Balance, end of period at Mar. 26, 2023 $ 931.2   $ 0.0 1,610.0 (0.5) (678.3)
Balance, beginning of period at Dec. 31, 2023   22.5        
Balance, end of period at Mar. 31, 2024   $ 22.5        
Balance, beginning of period (in shares) at Dec. 31, 2023 129,286,964   129,300,000      
Balance, beginning of period at Dec. 31, 2023 $ 976.0   $ 0.0 1,654.5 1.7 (680.2)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 9.2     9.2    
Issuance of common stock for employee stock purchase plan and stock options (in shares)     300,000      
Issuance of common stock for employee stock purchase plan and stock options 3.6     3.6    
Restricted stock issued and related taxes (in shares)     1,200,000      
Restricted stock issued and related taxes (15.1)     (15.1)    
Issuance of common stock for equity raise (in shares)     19,200,000      
Issuance of common stock for equity raise 330.7   $ 0.2 330.5    
Gain on interest rate swap contract 1.3       1.3  
Net income (loss) 1.3         1.3
Other comprehensive income (loss), net of tax $ (0.9)       (0.9)  
Balance, end of period (in shares) at Mar. 31, 2024 150,020,266   150,000,000.0      
Balance, end of period at Mar. 31, 2024 $ 1,306.1   $ 0.2 $ 1,982.7 $ 2.1 $ (678.9)